• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom study shows diabetes’ impact on mental health

June 12, 2023 By Sean Whooley

Dexcom G6 in action
The Dexcom G6. [Image courtesy of Dexcom]
A new study commissioned by Dexcom (Nasdaq:DXCM) found that diabetes has significant negative effects on mental health.

The study revealed that 84% of people surveyed agree that having diabetes can negatively impact mental health. It also demonstrated that nearly all participants (91%) believe technology enables a balanced lifestyle while managing diabetes.

Dexcom, a maker of continuous glucose monitor (CGM) technology, announced results ahead of the UK’s Diabetes Awareness Week. Censuswide conducted this research in April 2023 on behalf of the company. It included responses from 1,000 nationally representative U.K. respondents aged 16 years and up living with diabetes.

“As a pioneer and leader in real-time CGM, our goal at Dexcom is to simplify and improve diabetes management for every person with diabetes,” said Ben Byrne, Dexcom country director of U.K. and Ireland. “Dexcom CGM systems give people with diabetes a full picture of glucose numbers to help them better manage their condition – which, in turn, can help them go about their day with more confidence and less stress. This Diabetes Awareness Week and beyond, we’re proud to not only support the diabetes community with our products, but also educate the broader public on diabetes and the physical and mental effects it can have.”

In light of the survey’s findings, Dexcom announced that it plans to host “Puppy Yoga” classes in London. These classes promote mental health within the diabetes community.

Dexcom spokespeople, model Roxy Horner, and professional rugby player Henry Slade, will feature at the first class on June 17. The company said it opened the class to all living with diabetes and the broader public. Its aim is to encourage people to learn more about diabetes.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS